Evidence map›Paper›PMID 21910990›Full record

ReviewExperimental parasitology2012

Emodepside and SL0-1 potassium channels: a review.

R J Martin, S K Buxton, C Neveu, C L Charvet, A P Robertson

Abstract readReview
In one paragraph

Review in Experimental parasitology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Essential Oils as Novel Anthelmintic Drug Candidates.Molecules (Basel, Switzerland) · 2022
    Review
  4. Article
  5. Article
  6. Therapeutic peptides: current applications and future directions.Signal transduction and targeted therapy · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Expression of five acetylcholine receptor subunit genes in Brugia malayi adult worms.International journal for parasitology. Drugs and drug resistance · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Ion channels and drug transporters as targets for anthelmintics.Current clinical microbiology reports · 2014
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

R J MartinDepartment of Biomedical Sciences, Iowa State University, Ames, IA 50011-1250, USA. rjmartin@iastate.edu
S K Buxton
C Neveu
C L Charvet
A P Robertson
Iowa State University · USInfectiologie Animale et Santé Publique · FR

Funding

RESISTANCE &MODULATION OF LEVAMISOLE RECEPTOR CHANNELSR01AI047194 · NIAID · IOWA STATE UNIVERSITY · PI MARTIN, RICHARD JOHN · 2001 to 2021
$5.8M
Modulation of levamisole receptors: Pharmacological Diversity of Clade III nAChRsR56AI047194 · NIAID · IOWA STATE UNIVERSITY · PI MARTIN, RICHARD JOHN · 2011 to 2011
$382k
NIAID NIH HHS 2R56AI047194-11NIAID NIH HHS R01 AI047194NIAID NIH HHS R56 AI047194
6 · The paper itself

Abstract

Nematode parasites infect humans and domestic animals; treatment and prophylaxis require anthelmintic drugs because vaccination and sanitation is limited. Emodepside is a more recently introduced cyclooctadepsipeptide drug that has actions against GI nematodes, lungworm, and microfilaria. It has a novel mode of action which breaks resistance to the classical anthelmintics (benzimidazoles, macrocyclic lactones and cholinergic agonists). Here we review studies on its mode of action which suggest that it acts to inhibit neuronal and muscle activity of nematodes by increasing the opening of calcium-activated potassium (SLO-1) channels.

Indexed as

AnimalsAnthelminticsCaenorhabditis elegansDepsipeptidesDrug ResistanceHumansLarge-Conductance Calcium-Activated Potassium ChannelsMembrane PotentialsMuscle ContractionNematodaNematode InfectionsNeuromuscular JunctionNeuropeptidesReceptors, Peptidealpha-latrotoxin receptorAnthelminticsDepsipeptidesemodepsideLarge-Conductance Calcium-Activated Potassium ChannelsNeuropeptidesReceptors, Peptide

Identifiers

PMID21910990
PMCPMC3262936
OpenAlexW1984537682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.